by Jordana Choucair | Jul 14, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized Novavax Inc.’s two-dose COVID-19 shot for emergency use for adults, putting Americans one step away from a fourth vaccine option. Novavax, whose COVID-19 vaccine is the first in the U.S. that uses traditional...
by Jordana Choucair | Jul 14, 2022 | M&A
Molina Healthcare announced it plans to acquire Medicaid Managed Care Organization (MCO) My Choice Wisconsin. Joe Zubretsky, President and CEO of Molina Healthcare, said the acquisition is “representative of our strategic growth initiatives” and “demonstrates our...
by Jordana Choucair | Jul 14, 2022 | Opioid/Substance Use Disorders
A new study of fatal overdoses found that relaxing access to methadone did not lead to more deaths. In March 2020, the federal government told methadone clinics they could allow stable patients with opioid addiction to take their medicine at home unsupervised....
by Jordana Choucair | Jul 14, 2022 | Payers
Senator Joe Manchin said that he’s wary of adding an extension for enhanced subsidies for ACA plans to a slimmer reconciliation package, citing a fear of anything he believes would contribute “to the horrible inflation triggers we have.” Insurers and...
by Jordana Choucair | Jul 13, 2022 | Access & Coverage
The White House Council of Economic Advisers (CEA) authored a new issue brief revealing that states with high uninsured rates saw more “excess deaths” during the COVID-19 pandemic that stemmed from reasons like meager care in overwhelmed hospitals. The CEA...
by Jordana Choucair | Jul 13, 2022 | Life Sciences
The Food and Drug Administration (FDA) is expected to authorize Novavax’s coronavirus vaccine for emergency use as early as today. The authorization would likely permit the two-dose vaccine to be given to adults as a primary immunization series, limiting its use in...
Recent Comments